- Home
- APPN vs CPRX Comparison
APPN vs CPRX Comparison
Compare APPN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPN
- CPRX
- Stock Information
- Founded
- APPN 1999
- CPRX 2002
- Country
- APPN United States
- CPRX United States
- Employees
- APPN N/A
- CPRX N/A
- Industry
- APPN Computer Software: Prepackaged Software
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- APPN Technology
- CPRX Health Care
- Exchange
- APPN Nasdaq
- CPRX Nasdaq
- Market Cap
- APPN 2.6B
- CPRX 2.8B
- IPO Year
- APPN 2017
- CPRX 2006
- Fundamental
- Price
- APPN $33.34
- CPRX $21.62
- Analyst Decision
- APPN Hold
- CPRX Strong Buy
- Analyst Count
- APPN 7
- CPRX 8
- Target Price
- APPN $40.00
- CPRX $32.25
- AVG Volume (30 Days)
- APPN 516.5K
- CPRX 875.3K
- Earning Date
- APPN 02-19-2025
- CPRX 02-26-2025
- Dividend Yield
- APPN N/A
- CPRX N/A
- EPS Growth
- APPN N/A
- CPRX 114.68
- EPS
- APPN N/A
- CPRX 1.18
- Revenue
- APPN $617,022,000.00
- CPRX $460,482,000.00
- Revenue This Year
- APPN $14.93
- CPRX $24.00
- Revenue Next Year
- APPN $11.07
- CPRX $15.13
- P/E Ratio
- APPN N/A
- CPRX $18.37
- Revenue Growth
- APPN 13.14
- CPRX 32.17
- 52 Week Low
- APPN $26.28
- CPRX $13.70
- 52 Week High
- APPN $43.33
- CPRX $24.64
- Technical
- Relative Strength Index (RSI)
- APPN 47.28
- CPRX 40.14
- Support Level
- APPN $30.79
- CPRX $22.18
- Resistance Level
- APPN $41.05
- CPRX $23.59
- Average True Range (ATR)
- APPN 1.93
- CPRX 0.70
- MACD
- APPN 0.06
- CPRX -0.17
- Stochastic Oscillator
- APPN 24.85
- CPRX 11.30
About APPN Appian Corporation
Appian is a low-code enterprise platform-as-a-service company focusing on business process management. The Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. Most of Appian's revenue is subscription based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform, Appian Cloud.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.